Readers wishing to investigate their role in anti-tumor immunity are advised to use of the following markers: Siglec-F for eosinophils, FcεRIa for basophils, and CD117 (also known as c-Kit) for mast cells. This evidence concerns the gene FCER1A and neoplasm.